Evidence map›Paper›PMID 36597437›Full record

ArticleJournal of inflammation research2022

Analysis of Staged Features of Gastritis-Cancer Transformation and Identification of Potential Biomarkers in Gastric Cancer.

Ruikang Jia, Xiaohui Guo, Huiyun Liu, Feiyue Zhao, Zhibin Fan, Menglei Wang, Jianliang Sui, Binghua Yin, Zhihong Wang, Zhen Wang

Abstract read
In one paragraph

Article in Journal of inflammation research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. CHI3L1: a key driver in gastritis-to-cancer transformation.Journal of translational medicine · 2025
    Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ruikang Jia *The Affiliated Hospital and the Medical College, Hebei University of Engineering, Handan, Hebei Province, People's Republic of China.
Xiaohui Guo *Handan Central Hospital, Handan, Hebei Province, People's Republic of China.
Huiyun LiuKey Laboratory of Chinese Medicine for Gastric Medicine, Hebei Province, Handan Pharmaceutical Co. LTD, Handan, People's Republic of China.
Feiyue ZhaoKey Laboratory of Chinese Medicine for Gastric Medicine, Hebei Province, Handan Pharmaceutical Co. LTD, Handan, People's Republic of China.ORCID 0000-0003-2677-1631
Zhibin FanKey Laboratory of Chinese Medicine for Gastric Medicine, Hebei Province, Handan Pharmaceutical Co. LTD, Handan, People's Republic of China.
Menglei WangKey Laboratory of Chinese Medicine for Gastric Medicine, Hebei Province, Handan Pharmaceutical Co. LTD, Handan, People's Republic of China.
Jianliang SuiThe Affiliated Hospital and the Medical College, Hebei University of Engineering, Handan, Hebei Province, People's Republic of China.
Binghua YinHandan Central Hospital, Handan, Hebei Province, People's Republic of China.
Zhihong WangPeople's Hospital of Huangzhou District, Huanggang City, People's Republic of China.
Zhen WangThe Affiliated Hospital and the Medical College, Hebei University of Engineering, Handan, Hebei Province, People's Republic of China.ORCID 0000-0002-0308-6562

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: This work aims to elucidate the staged characteristics during gastritis-cancer transformation based on the transcriptome and use bioinformatics to identify potential biomarkers. Patients and Methods: We collected blood samples from healthy controls, patients with non-atrophic gastritis, atrophic gastritis, and gastric cancer, and tissue samples from patients with gastric cancer, respectively. RNA-seq was then performed. Differentially expressed genes, weighted gene co-expression network analysis and functional enrichment analysis were used to illustrate the staged characteristics of gastritis-cancer transformation. Genes with diagnostic potential were further identified in combination with ROC analysis. Additionally, for the gastric cancer stage, the gene expression of the collected tissue transcriptome was validated using the Cancer Genome Atlas and combined with survival analysis to identify potential biomarkers. Results: The 279 overlapping genes among the differentially expressed genes of NAG, AG and CA indicated that the expression characteristics of different stages were different. However, the 2243 overlapping genes of differential genes between adjacent stages indicated a certain consistency in the expression characteristics of stage development. The core functions of different stages have strong stage specificity and basically have no similarities. Twenty genes with diagnostic potential for AG or CA were obtained, respectively, and no gene could effectively differentiate NAG samples. Thirty-four potential biomarkers for gastric cancer were identified, of which 14 genes have not been reported, including ACTG2, C1QTNF2, NCAPH and SORCS1. Conclusion: There may be a stable development mechanism in the process of gastritis-carcinoma transformation, resulting in the differences in the performance of each stage. The newly discovered staging features and potential biomarkers in this work can provide references for related research.

Indexed as

bioinformaticsbiomarkergastritis-cancer transformationtranscriptome

Identifiers

PMID36597437
PMCPMC9805741

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.